EB in GA: Ratoff is Chairman of the Board. I think he is the ultimate decision maker at this point. Dr. Bruinsma might be the CEO, but that is understandable with Axonyx's European presence. Bruinsma probably understands the science better, and can more effectively present the company's progress at conferences, etc. But Ratoff has a long track record in the pharmaceutical industry, and he knows how to maximize shareholder value if he has something to sell. I think he did pretty well when he sold little Cima Labs to Cephalon. He'll do the same for Axonyx if Phenserine and/or Posiphen show some good efficacy. Axonyx is not going to take either drug to market by itself. A partnership with bigPharma or an outright sale of the company to bigPharma is the goal. If the science is there, Ratoff will make money for the shareholders.